Artwork

Inhalt bereitgestellt von Sal Daher. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Sal Daher oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
Player FM - Podcast-App
Gehen Sie mit der App Player FM offline!

Todd Zion, PhD - More Magical Proteins

45:31
 
Teilen
 

Manage episode 378751353 series 2519822
Inhalt bereitgestellt von Sal Daher. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Sal Daher oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.

Angel Scale Biotech: Learn More

Repeat founder Todd Zion, PhD is back to update us on exciting developments at his second biotech startup, Akston Bio. We also geeked out a bit on how these magical proteins are concocted in the company’s bioreactors. Fun and instructive chat with a stellar founder.

Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson.

Highlights:

  • Sal Daher Introduces Todd Zion
  • Akston Bio's Founding Story
  • "... The antigen in this case is the person's own insulin..."
  • "... you're still taking advantage of that antibody portion, but you've neutered it so that it no longer alerts the immune system, but it retains one property that antibodies all have, which is the ability to recycle and last for very long periods of time in circulation..."
  • "... We took the veterinary candidates and we partnered those with a company called Dechra Pharmaceuticals, PLC. They're one of the leaders in veterinary pharma development and this is all in the public domain..."
  • "... We made a pivot at that point saying, 'Well, what if we just go back to the portion of the antibody that interacts with the immune system and make ourselves a vaccine against COVID-19 using the same exact technology?'..."
  • "... you're going to continue involved in manufacturing, or are you just going to buckle down in the veterinary space and spin off these other technologies to other players?..."
  • "... if you're not pivoting at least once in your development, you're probably doing something wrong..."
  • Todd's Funding History
  • "... what goes on in a bioreactor, which is the heart of what you're doing? Geek out a little bit of bioreactors..."
  • "... there are these companies that do nothing but transfect CHO cells to produce particular types of protein..."
  • Energesis

Topics: biotech, COVID, discovering entrepreneurship

  continue reading

310 Episoden

Artwork
iconTeilen
 
Manage episode 378751353 series 2519822
Inhalt bereitgestellt von Sal Daher. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Sal Daher oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.

Angel Scale Biotech: Learn More

Repeat founder Todd Zion, PhD is back to update us on exciting developments at his second biotech startup, Akston Bio. We also geeked out a bit on how these magical proteins are concocted in the company’s bioreactors. Fun and instructive chat with a stellar founder.

Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson.

Highlights:

  • Sal Daher Introduces Todd Zion
  • Akston Bio's Founding Story
  • "... The antigen in this case is the person's own insulin..."
  • "... you're still taking advantage of that antibody portion, but you've neutered it so that it no longer alerts the immune system, but it retains one property that antibodies all have, which is the ability to recycle and last for very long periods of time in circulation..."
  • "... We took the veterinary candidates and we partnered those with a company called Dechra Pharmaceuticals, PLC. They're one of the leaders in veterinary pharma development and this is all in the public domain..."
  • "... We made a pivot at that point saying, 'Well, what if we just go back to the portion of the antibody that interacts with the immune system and make ourselves a vaccine against COVID-19 using the same exact technology?'..."
  • "... you're going to continue involved in manufacturing, or are you just going to buckle down in the veterinary space and spin off these other technologies to other players?..."
  • "... if you're not pivoting at least once in your development, you're probably doing something wrong..."
  • Todd's Funding History
  • "... what goes on in a bioreactor, which is the heart of what you're doing? Geek out a little bit of bioreactors..."
  • "... there are these companies that do nothing but transfect CHO cells to produce particular types of protein..."
  • Energesis

Topics: biotech, COVID, discovering entrepreneurship

  continue reading

310 Episoden

Alle Folgen

×
 
Loading …

Willkommen auf Player FM!

Player FM scannt gerade das Web nach Podcasts mit hoher Qualität, die du genießen kannst. Es ist die beste Podcast-App und funktioniert auf Android, iPhone und im Web. Melde dich an, um Abos geräteübergreifend zu synchronisieren.

 

Kurzanleitung